If Veyonda can replicate the results for abscopal response and pain relief from DARRT-1 in a larger sample group and across multiple cancer types, the SP would hopefully fall in line with what is expected of a possible SOC drug for Stage IV treatment. Prostate cancer killed 34130 people in the US in 2021.
Will GK go with one last update on his way out or could GM open her campaign with a bang?
- Forums
- ASX - By Stock
- How can we do better?
If Veyonda can replicate the results for abscopal response and...
Featured News
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $22.21M |
Open | High | Low | Value | Volume |
7.5¢ | 7.7¢ | 7.3¢ | $10.34K | 136.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3392 | 7.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.9¢ | 48932 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10016 | 0.071 |
1 | 100000 | 0.070 |
1 | 43261 | 0.069 |
2 | 21132 | 0.068 |
1 | 77000 | 0.066 |
Price($) | Vol. | No. |
---|---|---|
0.079 | 48932 | 1 |
0.080 | 100000 | 1 |
0.081 | 10000 | 1 |
0.085 | 11763 | 1 |
0.086 | 100000 | 1 |
Last trade - 14.24pm 09/08/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |